By Dr Michael Falster

Journal articles

Neuen BL; Ostrominski JW; Claggett B; Beldhuis IE; Chatur S; McCausland FR; Badve SV; Arnott C; Heerspink HJL; Jun M; Falster M; de Oliveira Costa J; Pollock C; Jardine MJ; Mahaffey KW; Perkovic V; Solomon SD; Vaduganathan M, 2024, 'Bidirectional Relationship Between Kidney Disease Progression and Cardiovascular Events in Type 2 Diabetes', Journal of the American College of Cardiology, 84, pp. 2246 - 2250, http://dx.doi.org/10.1016/j.jacc.2024.08.006

Daniels B; Luckett T; Liauw W; Falster MO; Gisev N; Blyth FM; Pearson SA, 2024, 'Trajectories of Opioid Use Before and After Cancer Diagnosis: A Population-Based Cohort Study', Journal of Pain and Symptom Management, 68, pp. 282 - 291.e11, http://dx.doi.org/10.1016/j.jpainsymman.2024.06.006

Deakin CT; Costa JDO; Brieger D; Lin J; Schaffer AL; Kidd M; Pearson S-A; Falster MO, 2024, 'Post-discharge pharmacotherapy in people with atrial fibrillation hospitalised for acute myocardial infarction: an Australian cohort study 2018-2022.', Eur Heart J Qual Care Clin Outcomes, http://dx.doi.org/10.1093/ehjqcco/qcae068

af Geijerstam P; Falster MO; Chalmers J; McLachlan AJ; Rodgers A; Schutte AE, 2024, 'Prescription and dispensing duration of medicines for hypertension and other chronic conditions: a review of international policies and evidence to inform the Australian setting', Hypertension Research, 47, pp. 2104 - 2114, http://dx.doi.org/10.1038/s41440-024-01743-2

Zoega H; Falster M; Gillies M; Litchfield M; Camacho X; Bruno C; Daniels B; Donnolley N; Havard A; Schaffer A; Chambers G; Degenhardt L; Dobbins T; Gisev N; Ivers R; Jorm L; Liu B; Vajdic C; Pearson SA, 2024, 'The Medicines Intelligence Data Platform: A Population-Based Data Resource From New South Wales, Australia', Pharmacoepidemiology and Drug Safety, 33, http://dx.doi.org/10.1002/pds.5887

de Oliveira Costa J; Lin J; Milder TY; Greenfield JR; Day RO; Stocker SL; Neuen BL; Havard A; Pearson SA; Falster MO, 2024, 'Geographic variation in sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide-1 receptor agonist use in people with type 2 diabetes in New South Wales, Australia', Diabetes, Obesity and Metabolism, 26, pp. 2787 - 2795, http://dx.doi.org/10.1111/dom.15597

Lin J; De Oliveira Costa J; Pearson SA; Buckley NA; Brieger D; Schutte AE; Schaffer AL; Falster MO, 2024, 'Impact of coordinated care on adherence to antihypertensive medicines among adults experiencing polypharmacy in Australia', Journal of Hypertension, 42, pp. 1248 - 1255, http://dx.doi.org/10.1097/HJH.0000000000003721

Tran DT; Falster MO; Pearse J; Mazevska D; McElduff P; Pearson S; van Gool KC; Hall J; Jorm L, 2024, 'The Australian Health Care Homes trial: quality of care and patient outcomes. A propensity score-matched cohort study', Medical Journal of Australia, 220, pp. 372 - 378, http://dx.doi.org/10.5694/mja2.52266

Stehlik P; Dowsett C; Camacho X; Falster MO; Lim R; Nasreen S; Pratt NL; Pearson SA; Henry D, 2024, 'Evolution of the data and methods in real-world COVID-19 vaccine effectiveness studies on mortality: a scoping review protocol', BMJ Open, 14, pp. e079071, http://dx.doi.org/10.1136/bmjopen-2023-079071

Neuen BL; Heerspink HJL; Vart P; Claggett BL; Fletcher RA; Arnott C; de Oliveira Costa J; Falster MO; Pearson SA; Mahaffey KW; Neal B; Agarwal R; Bakris G; Perkovic V; Solomon SD; Vaduganathan M, 2024, 'Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria', Circulation, 149, pp. 450 - 462, http://dx.doi.org/10.1161/CIRCULATIONAHA.123.067584

Milder TY; Lin J; Pearson SA; de Oliveira Costa J; Neuen BL; Pollock C; Jun M; Greenfield JR; Day RO; Stocker SL; Brieger D; Falster MO, 2024, 'Discontinuation of SGLT2i in people with type 2 diabetes following hospitalisation for heart failure: A cause for concern?', Diabetes, Obesity and Metabolism, http://dx.doi.org/10.1111/dom.16061

Milder TY; Lin J; Pearson SA; Greenfield JR; Day RO; Stocker SL; Neuen BL; Falster MO; de Oliveira Costa J, 2024, 'Use of, time to, and type of first add-on anti-hyperglycaemic therapy to metformin in Australia, 2018–2022', British Journal of Clinical Pharmacology, http://dx.doi.org/10.1111/bcp.16231

de Oliveira Costa J; Pearson SA; Brieger D; Lujic S; Shawon MSR; Jorm LR; van Gool K; Falster MO, 2023, 'In-hospital outcomes by insurance type among patients undergoing percutaneous coronary interventions for acute myocardial infarction in New South Wales public hospitals', International Journal for Equity in Health, 22, pp. 226, http://dx.doi.org/10.1186/s12939-023-02030-1

Sotade OT; Falster MO; Pearson SA; Jorm LR; Sedrakyan A, 2023, 'Comparison of long-term outcomes of bioprosthetic and mechanical aortic valve replacement in patients younger than 65 years', Journal of Thoracic and Cardiovascular Surgery, 166, pp. 728 - 737.e13, http://dx.doi.org/10.1016/j.jtcvs.2022.01.016

Mao J; Behrendt CA; Falster MO; Varcoe RL; Zheng X; Peters F; Beiles B; Schermerhorn ML; Jorm L; Beck AW; Sedrakyan A, 2023, 'Long-term Mortality and Reintervention after Endovascular and Open Abdominal Aortic Aneurysm Repairs in Australia, Germany, and the United States', Annals of Surgery, 278, pp. E626 - E633, http://dx.doi.org/10.1097/SLA.0000000000005768

Lin J; Pearson SA; Greenfield JR; Park KH; Havard A; Brieger D; Day RO; Falster MO; de Oliveira Costa J, 2023, 'Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) in Australia in the era of increased evidence of their cardiovascular benefits (2014–2022)', European Journal of Clinical Pharmacology, 79, pp. 1239 - 1248, http://dx.doi.org/10.1007/s00228-023-03539-8

Costa JDO; Lin J; Pearson SA; Buckley NA; Schaffer AL; Falster MO; de Oliveira Costa J, 2023, 'Persistence and Adherence to Cardiovascular Medicines in Australia', Journal of the American Heart Association, 12, pp. e030264, http://dx.doi.org/10.1161/JAHA.122.030264

Robijn AL; Filion KB; Woodward M; Hsu B; Chow CK; Pearson SA; Jorm L; Falster MO; Havard A, 2023, 'Comparative effect of varenicline and nicotine patches on preventing repeat cardiovascular events', Heart, 109, pp. 1016 - 1024, http://dx.doi.org/10.1136/heartjnl-2022-322170

Garland SK; Falster MO; Beiles CB; Freeman AJ; Jorm LR; Sedrakyan A; Sotade O; Varcoe RL, 2023, 'Long-Term Outcomes Following Elective Repair of Intact Abdominal Aortic Aneurysms: A Comparison Between Open Surgical and Endovascular Repair Using Linked Administrative and Clinical Registry Data', Annals of Surgery, 277, pp. E955 - E962, http://dx.doi.org/10.1097/SLA.0000000000005259

Shawon MSR; Falster MO; Hsu B; Yu J; Ooi SY; Jorm L, 2023, 'Trends and Outcomes for Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in New South Wales from 2008 to 2019', American Journal of Cardiology, 187, pp. 110 - 118, http://dx.doi.org/10.1016/j.amjcard.2022.10.047

Falster MO; Garland SK; Jorm LR; Beiles CB; Freeman AJ; Sedrakyan A; Sotade OT; Varcoe RL, 2023, 'Editor's Choice – Comparison of outcomes for major contemporary endograft devices used for endovascular repair of intact abdominal aortic aneurysms', European Journal of Vascular and Endovascular Surgery, 65, pp. 272 - 280, http://dx.doi.org/10.1016/j.ejvs.2022.11.005

Quiroz JC; Brieger D; Jorm LR; Sy RW; Falster MO; Gallego B, 2022, 'An Observational Study of Clinical and Health System Factors Associated With Catheter Ablation and Early Ablation Treatment for Atrial Fibrillation in Australia', Heart Lung and Circulation, 31, pp. 1269 - 1276, http://dx.doi.org/10.1016/j.hlc.2022.04.049

Lujic S; Randall DA; Simpson JM; Falster MO; Jorm LR, 2022, 'Interaction effects of multimorbidity and frailty on adverse health outcomes in elderly hospitalised patients', Scientific Reports, 12, pp. 14139, http://dx.doi.org/10.1038/s41598-022-18346-x

Sotade OT; Jorm LR; Kushwaha VV; Yu J; Sedrakyan A; Falster MO; Pearson SA, 2022, 'Post-Discharge Antithrombotic Therapy Following Transcatheter Aortic Valve Implantation in Australian Patients', Heart Lung and Circulation, 31, pp. 1144 - 1152, http://dx.doi.org/10.1016/j.hlc.2022.04.048

Sotade OT; Pearson SA; Jorm LR; Kushwaha VV; Sedrakyan A; Falster MO, 2022, 'Changing Practice: Procedural Volume of Transcatheter Aortic Valve Implantation by Age and Funding in New South Wales, 2002–2018', Heart Lung and Circulation, 31, pp. e17 - e19, http://dx.doi.org/10.1016/j.hlc.2021.09.010

Falster MO; Schaffer AL; Wilson A; Nasis A; Jorm LR; Hay M; Leeb K; Pearson SA; Brieger D, 2022, 'Evidence-practice gaps in P2Y12 inhibitor use after hospitalisation for acute myocardial infarction: findings from a new population-level data linkage in Australia', Internal Medicine Journal, 52, pp. 249 - 258, http://dx.doi.org/10.1111/imj.15036

Schaffer AL; Chia J; Brett J; Pearson S; Falster MO, 2022, 'A nationwide study of multimedicine use in people treated with cardiovascular medicines in Australia', Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, 42, pp. 828 - 836, http://dx.doi.org/10.1002/phar.2735

De Oliveira Costa J; Pearson SA; Elshaug AG; Van Gool K; Jorm LR; Falster MO, 2021, 'Rates of Low-Value Service in Australian Public Hospitals and the Association with Patient Insurance Status', JAMA Network Open, 4, pp. e2138543, http://dx.doi.org/10.1001/jamanetworkopen.2021.38543

Shawon MSR; Odutola M; Falster MO; Jorm LR, 2021, 'Patient and hospital factors associated with 30-day readmissions after coronary artery bypass graft (CABG) surgery: a systematic review and meta-analysis', Journal of Cardiothoracic Surgery, 16, pp. 172, http://dx.doi.org/10.1186/s13019-021-01556-1

Lujic S; Randall D; Simpson J; Falster M; Jorm L, 2021, '1467Interaction effects of multimorbidity and frailty on adverse health outcomes in elderly hospitalised patients', International Journal of Epidemiology, 50, http://dx.doi.org/10.1093/ije/dyab168.402

Falster MO; Charrier R; Pearson SA; Buckley NA; Daniels B, 2021, 'Long-term trajectories of medicine use among older adults experiencing polypharmacy in Australia', British Journal of Clinical Pharmacology, 87, pp. 1264 - 1274, http://dx.doi.org/10.1111/bcp.14504

Quiroz JC; Brieger D; Jorm L; Sy RW; Falster MO; Gallego B, 2021, 'An observational study of clinical and health system factors associated with catheter ablation and early ablation treatment for atrial fibrillation in Australia', , pp. 2021.09.03.21263104, http://dx.doi.org/10.1101/2021.09.03.21263104

Sotade OT; Falster M; Girardi LN; Pearson SA; Jorm LR, 2020, 'Age-stratified outcomes of bioprosthetic and mechanical aortic valve replacements in an Australian cohort of 13 377 patients', BMJ Surgery, Interventions, and Health Technologies, 2, pp. e000036, http://dx.doi.org/10.1136/bmjsit-2020-000036

Falster MO; Buckley NA; Brieger D; Pearson SA, 2020, 'Antihypertensive polytherapy in Australia: Prevalence of inappropriate combinations, 2013-2018', Journal of Hypertension, 38, pp. 1586 - 1592, http://dx.doi.org/10.1097/HJH.0000000000002408

Hsu B; Falster MO; Schaffer AL; Pearson S; Jorm L; Brieger DB, 2020, 'Antiplatelet therapy within 30 days of percutaneous coronary intervention with stent implantation', Medical Journal of Australia, 213, pp. 124 - 125, http://dx.doi.org/10.5694/mja2.50507

Darshni A; Farshid A; MacIsaac A; Hsu B; Pearson S; Falster M; Hyun K; D'Silva M; Brieger D, 2020, '730 Exploration of Single Antiplatelet Drug use in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention and Cardiac Stenting', Heart, Lung and Circulation, 29, pp. S364 - S365, http://dx.doi.org/10.1016/j.hlc.2020.09.737

Coleman L; Brett J; Daniels B; Pearson S; Falster M, 2020, 'Medicine reviews: do they reduce benzodiazepine use in older Australians?', Public Health Research & Practice, 31, http://dx.doi.org/10.17061/phrp30452015

Page AT; Falster MO; Litchfield M; Pearson SA; Etherton-Beer C, 2019, 'Polypharmacy among older Australians, 2006–2017: a population-based study', Medical Journal of Australia, 211, pp. 71 - 75, http://dx.doi.org/10.5694/mja2.50244

Falster MO; Leyland AH; Jorm LR, 2019, 'Do hospitals influence geographic variation in admission for preventable hospitalisation? A data linkage study in New South Wales, Australia', BMJ Open, 9, http://dx.doi.org/10.1136/bmjopen-2018-027639

Schaffer AL; Falster MO; Brieger D; Jorm LR; Wilson A; Hay M; Leeb K; Pearson S; Nasis A, 2019, 'Evidence-practice gaps in postdischarge initiation with oral anticoagulants in patients with atrial fibrillation', Journal of the American Heart Association, 8, pp. e014287, http://dx.doi.org/10.1161/JAHA.119.014287

Tran B; Falster M; Jorm L, 2018, 'Claims-based measures of continuity of care have non-linear associations with health: data linkage study', International Journal of Population Data Science, 3, pp. 463, http://dx.doi.org/10.23889/ijpds.v3i1.463

Falster MO; Jorm LR; Leyland AH, 2018, 'Using Weighted Hospital Service Area Networks to Explore Variation in Preventable Hospitalization', Health Services Research, 53, pp. 3148 - 3169, http://dx.doi.org/10.1111/1475-6773.12777

Tran B; Straka P; Falster MO; Douglas KA; Britz T; Jorm LR, 2018, 'Overcoming the data drought: Exploring general practice in Australia by network analysis of big data', Medical Journal of Australia, 209, pp. 68 - 73, http://dx.doi.org/10.5694/mja17.01236

Johnson TL; Kaldor J; Falster MO; Sutherland K; Humphries J; Jorm LR; Levesque JF, 2018, 'Predictive risk modelling under different data access scenarios: Who is identified as high risk and for how long?', BMJ Open, 8, pp. e018909, http://dx.doi.org/10.1136/bmjopen-2017-018909

Van Leeuwen MT; Falster MO; Vajdic CM; Crowe PJ; Lujic S; Klaes E; Jorm L; Sedrakyan A, 2018, 'Reoperation after breast-conserving surgery for cancer in Australia: Statewide cohort study of linked hospital data', BMJ Open, 8, pp. e020858, http://dx.doi.org/10.1136/bmjopen-2017-020858

Falster M; Jorm L; Leyland A, 2017, 'Exploring health events around preventable hospitalisations through visualisation of linked health data.', International Journal of Population Data Science, 1, http://dx.doi.org/10.23889/ijpds.v1i1.103

Falster M; Jorm L; Leyland A, 2017, 'Using weighted hospital service area networks to explore variation in preventable hospitalisation.', International Journal of Population Data Science, 1, http://dx.doi.org/10.23889/ijpds.v1i1.104

Möller H; Falster K; Ivers R; Falster MO; Clapham K; Jorm L, 2017, 'Closing the Aboriginal child injury gap: targets for injury prevention', Australian and New Zealand Journal of Public Health, 41, pp. 8 - 14, http://dx.doi.org/10.1111/1753-6405.12591

Falster K; Banks E; Lujic S; Falster M; Lynch J; Zwi K; Eades S; Leyland AH; Jorm L, 2016, 'Inequalities in pediatric avoidable hospitalizations between Aboriginal and non-Aboriginal children in Australia: A population data linkage study', BMC Pediatrics, 16, http://dx.doi.org/10.1186/s12887-016-0706-7

Möller H; Falster K; Ivers R; Falster M; Randall D; Clapham K; Jorm L, 2016, 'Inequalities in hospitalized unintentional injury between aboriginal and non-aboriginal children in New South Wales, Australia', American Journal of Public Health, 106, pp. 899 - 905, http://dx.doi.org/10.2105/AJPH.2015.303022

Back to profile page